Clinical Trial Update: Effectiveness and Safety of Platelet Rich Plasma (PRP) on Persistent Olfactory Dysfunction Related to COVID-19 [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluated the effectiveness and safety of platelet-rich plasma (PRP) for persistent olfactory dysfunction related to COVID-19 (…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anosmia

Drugs mentioned

• Platelet-rich plasma (platelet-rich plasma)

Snippet

Sponsor: Centre Hospitalier Universitaire Saint Pierre | Conditions: Anosmia, COVID-19 | Phase 2, Phase 3 | Status: COMPLETED